The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 25th 2025
NCCN updates colon cancer guidelines, emphasizing testing for DPYD gene variants before initiating fluoropyrimidine-based chemotherapy.
Lawsuit Challenges States’ Ability to Bar Access to Mifepristone
March 16th 2023Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.
Read More
Closed-System Transfer Devices Reduce Exposure to Contaminants
When choosing an appropriate system, pharmacists must consider all data, as not all CSTDs are equally effective.
Read More
Durvalumab Improves Event-Free Survival in Resectable Non–Small Cell Lung Cancer
March 15th 2023Adding durvalumab to neoadjuvant chemotherapy to treat resectable early-stage non–small cell lung cancer did not increase complications and adverse events or comprise patients’ ability to undergo surgery versus chemotherapy alone.
Read More
Pharmacy Focus: Student Edition - The Granada Statements
March 13th 2023Shane Desselle, RPh, PhD, FAPhA, associate dean for Research and Professional Affairs at the Touro University California College of Pharmacy, discusses what the Granada Statements are and why they are important for student pharmacists.
Listen
Merck Discontinues Trials of Pembrolizumab in Prostate Cancer, Non–Small Cell Lung Cancer
March 13th 2023The KEYNOTE-641 and -789 trials did not demonstrate improvements or meet the primary endpoints in metastatic castration-resistant prostate cancer and metastatic nonsquamous non–small cell lung cancer.
Read More
FDA Advisory Committee Supports Polatuzumab for Previously Untreated Diffuse Large B-cell Lymphoma
March 10th 2023On April 2, 2023, the FDA will announce the approval status of Roche’s supplemental Biologics License Application for polatuzumab in the treatment of diffuse large B-cell lymphoma.
Read More